Back to Results
First PageMeta Content
Medical tests / Epidemiology / Newborn screening / Pediatrics / Informed consent / Screening / Genetic testing / Minors and abortion / Association of Public Health Laboratories / Health / Medicine / Medical ethics


Newborn Screening, Banking, and Consent Claude Laberge(1), Linda Kharaboyan(2), Denise Avard[removed]Université Laval du Québec, Faculté de médecine (2) Université de Montréal, Centre de recherche en droit public I
Add to Reading List

Document Date: 2006-10-31 11:50:34

Open Document

File Size: 165,33 KB

Share Result on Facebook

City

Amsterdam / Laval / New York / /

Company

AAP / /

Country

United States / Canada / United Kingdom / Scotland / Denmark / /

IndustryTerm

subsequent processing / microarray technology / actual research protocol / possible health services / healthcare providers / /

MedicalCondition

untreatable diseases / inborn disorders / additional disorders / HIV / untreatable disorders / disease / certain diseases / treatable and untreatable disorders / treatable disorders / congenital hypothyroidism / non-treatable disorders / diseases / disorder / PKU / sickle cell disease / treatable diseases / treatable disorder / cystic fibrosis / MS / disorders / /

MedicalTreatment

invasive procedures / counselling / /

Organization

World Health Organisation / UK Newborn Screening Programme Centre / Association of Public Health Laboratories / Institute of Medicine / Human Genetics Society of Australasia / International Society for Neonatal Screening / American Academy of Pediatrics Newborn Screening Taskforce / New York Task Force / United Nations Educational Scientific and Cultural Organization / /

Person

Claude M. Laberge / Denise Avard / Linda Kharaboyan / /

Position

pilot program / obstetrician / /

ProvinceOrState

Wyoming / Maryland / New York / /

RadioStation

WHO 42 / /

Technology

actual research protocol / DNA chip / diagnostic tests / DNA microarray technology / /

SocialTag